SEC Form D filing

Dualitas Therapeutics, Inc., 2025-11-18

An SEC Form D private-offering notice from South San Francisco, CA, a $66,599,990 filer-stated offering target in Biotech. Filed 2025-11-18. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Dualitas Therapeutics, Inc. site↗ Verified via SEC Form D

Develops bispecific antibody medicines for immune and inflammatory disease using its DualScreen discovery engine.

Filed 2025-11-18Filed to raise $66,599,990First money in 2025-07-07Raised so far $32,599,997HQ (as filed) South San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified dualitastx.com↗Named in the filing 9 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source